Marc C. Levesque

6.8k total citations · 1 hit paper
124 papers, 4.6k citations indexed

About

Marc C. Levesque is a scholar working on Rheumatology, Immunology and Hepatology. According to data from OpenAlex, Marc C. Levesque has authored 124 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 29 papers in Immunology and 22 papers in Hepatology. Recurrent topics in Marc C. Levesque's work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Rheumatoid Arthritis Research and Therapies (17 papers). Marc C. Levesque is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Rheumatoid Arthritis Research and Therapies (17 papers). Marc C. Levesque collaborates with scholars based in United States, France and Canada. Marc C. Levesque's co-authors include Philippe Soyer, Barton F. Haynes, J. Brice Weinberg, Dominique Elias, Rohit Aggarwal, Guy Zeitoun, Chester V. Oddis, E. William St. Clair, Maurine R. Hobbs and Dana P. Ascherman and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Blood.

In The Last Decade

Marc C. Levesque

122 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial

2012 448 citations Chester V. Oddis, Rohit Aggarwal et al. profile →

Peers

Countries citing papers authored by Marc C. Levesque

Since Specialization

Citations

This map shows the geographic impact of Marc C. Levesque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc C. Levesque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc C. Levesque more than expected).

Fields of papers citing papers by Marc C. Levesque

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc C. Levesque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc C. Levesque. The network helps show where Marc C. Levesque may publish in the future.

Co-authorship network of co-authors of Marc C. Levesque

This figure shows the co-authorship network connecting the top 25 collaborators of Marc C. Levesque. A scholar is included among the top collaborators of Marc C. Levesque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc C. Levesque. Marc C. Levesque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synovial Inflammatory Pathways Characterize Anti‐TNF–Responsive Rheumatoid Arthritis Patients 2022 ·Arthritis & Rheumatology ·(unknown), Donna Conlon, Felice Rivellese, Alessandra Nerviani, Myles Lewis, William Housley, Marc C. Levesque, Xiaohong Cao, Carolyn A. Cuff, Andrew J. Long, Costantino Pitzalis, Melanie C. Ruzek	19
2	Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis 2018 ·Annals of the Rheumatic Diseases ·M. Kloppenburg, Charles Peterfy, I.K. Haugen, Féline P B Kroon, Su Chen, Li Wang, Wei Liu, G Levy, Roy Fleischmann, Francis Bérenbaum, Désirée van der Heijde, Prashant Bansal, Ruth Wittoek, Sheng Feng, (unknown), Mary Saltarelli, Jan Paul Medema, Marc C. Levesque	130
3	Longitudinal Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System (TOMS) 2018 ·The Journal of Rheumatology ·Féline P B Kroon, (unknown), Frédérique Gandjbakhch, Charles Peterfy, Su Chen, Philip G. Conaghan, Iris Eshed, Violaine Foltz, Harry K. Genant, I.K. Haugen, Jan Paul Medema, Mikkel Østergaard, Lanju Zhang, Marc C. Levesque, M. Kloppenburg	5
4	Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker 2016 ·Arthritis Research & Therapy ·(unknown), G.K. Balasubramani, (unknown), Marc C. Levesque, S. Louis Bridges, Larry W. Moreland	46
5	Complement Component C5a Permits the Coexistence of Pathogenic Th17 Cells and Type I IFN in Lupus 2014 ·The Journal of Immunology ·Sudesh Pawaria, Kritika Ramani, (unknown), Youhua Liu, Larry Kane, Marc C. Levesque, Partha S. Biswas	19
6	Predictors of Clinical Improvement in Rituximab‐Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis 2013 ·Arthritis & Rheumatology ·Rohit Aggarwal, Andriy I. Bandos, Ann M. Reed, Dana P. Ascherman, Richard J. Barohn, Brian M. Feldman, Frederick W. Miller, Lisa G. Rider, Michael O. Harris‐Love, Marc C. Levesque, (unknown), (unknown)	190
7	Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses 2012 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Jianmin Xue, Arpit Bhargava, Eva Csizmadia, Leo E. Otterbein, Daniel J. Kass, Jessica Bon, Makoto Soejima, Marc C. Levesque, Kathleen O. Lindell, Kevin F. Gibson, Naftali Kaminski, (unknown), Chester V. Oddis, Joseph M. Pilewski, Frank C. Sciurba, Michael P. Donahoe, Yingze Zhang, Steven R. Duncan	134
8	Clinical course of Crohnʼs disease following treatment of lymphoma 2011 ·Inflammatory Bowel Diseases ·(unknown), Jana G. Hashash, (unknown), Mazen Issa, Jeffry Katz, (unknown), Arthur Barrie, Leonard Baidoo, Marc Schwartz, Jason M. Swoger, Marc C. Levesque, David G. Binion	10
9	Activation-Induced Cytidine Deaminase Expression and Activity in the Absence of Germinal Centers: Insights into Hyper-IgM Syndrome 2009 ·The Journal of Immunology ·Masayuki Kuraoka, Dongmei Liao, Kaiyong Yang, Sallie D. Allgood, Marc C. Levesque, Garnett Kelsoe, Yoshihiro Ueda	42
10	Characterization of cadmium uptake and cytotoxicity in human osteoblast-like MG-63 cells 2008 ·Toxicology and Applied Pharmacology ·Marc C. Levesque, Corine Martineau, Catherine Jumarie, Richard Moreau	52
11	INDUCIBLE NITRIC OXIDE SYNTHASE (NOS2) PROMOTER CCTTT REPEAT POLYMORPHISM: RELATIONSHIP TO IN VIVO NITRIC OXIDE PRODUCTION/NOS ACTIVITY IN AN ASYMPTOMATIC MALARIA-ENDEMIC POPULATION 2003 ·American Journal of Tropical Medicine and Hygiene ·Craig S. Boutlis, Maurine R. Hobbs, Robyn L. Marsh, Mary A. Misukonis, Ariana N. Tkachuk, Moses Lagog, (unknown), Donald L. Granger, Moses J. Bockarie, Charles S. Mgone, Marc C. Levesque, J. Brice Weinberg, Nicholas M. Anstey	21
12	IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells 2003 ·Leukemia ·Marc C. Levesque, Mary A. Misukonis, (unknown), (unknown), (unknown), (unknown), David J. Adams, R Silber, J. Brice Weinberg	35
13	A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children 2002 ·The Lancet ·Maurine R. Hobbs, Venkatachalam Udhayakumar, Marc C. Levesque, (unknown), Jacquelin M. Roberts, Ariana N. Tkachuk, Ann Pole, Hilary Coon, Simon Kariuki, Bernard L. Nahlen, Esther D. Mwaikambo, (unknown), Donald L. Granger, Nicholas M. Anstey, J. Brice Weinberg	150
14	Activated T Lymphocytes Regulate Hyaluronan Binding to Monocyte CD44 Via Production of IL-2 and IFN-γ 2001 ·The Journal of Immunology ·Marc C. Levesque, Barton F. Haynes	20
15	Haemoperitoneum due to spontaneous rupture of hepatic haemangiomatosis: Treatment by superselective arterial embolization and partial hepatectomy 1995 ·Australasian Radiology ·P. Soyer, Marc C. Levesque	25
16	CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. 1994 ·American Journal of Roentgenology ·Philippe Soyer, David A. Bluemke, C Vissuzaine, Bernard E. Van Beers, (unknown), Marc C. Levesque	45
17	Involvement of superior mesenteric vessels and portal vein in pancreatic adenocarcinoma: Detection with CT during arterial portography 1994 ·Abdominal Imaging ·Philippe Soyer, (unknown), (unknown), Marc C. Levesque	2
18	False-positive CT portography: correlation with pathologic findings. 1993 ·American Journal of Roentgenology ·Philippe Soyer, (unknown), Marc C. Levesque	75
19	Hepatic metastases from colorectal cancer: influence of hepatic volumetric analysis on surgical decision making. 1992 ·Radiology ·Philippe Soyer, (unknown), Dominique Elias, Marc C. Levesque	99
20	[Protein-losing enteropathy caused by intestinal metastases of melanosarcoma]. 1989 ·PubMed ·(unknown), (unknown), (unknown), Jean‐Pierre Guichard, Marc C. Levesque	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact